Bradley Evan Burnam - Chief Executive Officer, Director, 10%+ Owner at Turn Therapeutics Inc.

Issuer-level insider activity

Role
Chief Executive Officer, Director, 10%+ Owner
Issuer ticker
TTRX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Bradley Evan Burnam since 12 Aug 2025

Reported holdings for Bradley Evan Burnam in Turn Therapeutics Inc.

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Turn Therapeutics Inc.

Security class
Common Stock
Shares / value
15,116,260
Estimated value
$48,372,032
Report date
28 May 2026
Price
$3.20
Ownership
By BEB Holdings, LLC
Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Turn Therapeutics Inc.

Security class
Employee stock option (right to buy)
Shares / value
160,000
Estimated value
Report date
01 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Turn Therapeutics Inc.

Security class
Employee stock option (right to buy)
Shares / value
160,000
Estimated value
Report date
01 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Bradley Evan Burnam in Turn Therapeutics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .